Semnur Pharmaceuticals (SMNR) Non-Current Assets (2022 - 2026)
Semnur Pharmaceuticals (SMNR) recorded Non-Current Assets of $750,000 in Q2 2026, up 36.8% from $548,318 a year earlier and unchanged from the prior quarter.
Powered by 
Analysis
Semnur Pharmaceuticals (SMNR) Non-Current Assets (2022 - 2026) Analysis & Trends
Starting with Q1 2022, Semnur Pharmaceuticals' Non-Current Assets history includes 18 quarters.
- Annual Non-Current Assets has a three-year compound annual growth rate of -79.4% (FY2022 to FY2025).
- Across earlier years, Non-Current Assets came in at $689,000 in FY2024 (-98.6%), $50.48 million in FY2023 (-40.9%) and $85.37 million in FY2022.
- Quarterly Non-Current Assets has ranged from $425,315 in Q1 2022 to $90.11 million in Q3 2023 over the past five years.
- On a year-over-year basis, Non-Current Assets rose in two of the last eight quarters, with an average decline of 63.5%.
- Peak year-over-year performance for Non-Current Assets in the last five years was growth of 36.8% in Q2 2026, against a decline of 98.9% in Q2 2025 at the low end.
- Per Business Quant, the preceding three quarters came in at $750,000 (Q1 2026), $750,000 (Q4 2025) and $689,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,199.50 Bn | 1,168.08 Bn | 19.71 Bn | 77.61 Bn |
| 2 | Johnson & Johnson | 635.17 Bn | 555.03 Bn | 17.30 Bn | 141.07 Bn |
| 3 | AbbVie | 504.69 Bn | 477.85 Bn | 12.70 Bn | 101.45 Bn |
| 4 | Merck | 358.43 Bn | 312.86 Bn | 12.21 Bn | 125.00 Mn |
| 5 | Novartis Ag | 288.36 Bn | 252.75 Bn | 11.24 Bn | 94.68 Bn |
| 6 | Astrazeneca | 265.78 Bn | 239.54 Bn | 12.86 Bn | 87.87 Bn |
| 7 | Amgen | 237.46 Bn | 192.86 Bn | 7.24 Bn | 60.68 Bn |
| 8 | Gilead Sciences | 193.65 Bn | 167.76 Bn | 6.22 Bn | 35.42 Bn |
| 9 | Pfizer | 171.05 Bn | 118.00 Bn | 10.94 Bn | 159.77 Bn |
| 10 | Semnur Pharmaceuticals | 85.18 Mn | 84.92 Mn | - | 750,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 750,000.00 |
| Mar 31, 2026 | 750,000.00 |
| Dec 31, 2025 | 750,000.00 |
| Sep 30, 2025 | 689,000.00 |
| Jun 30, 2025 | 548,318.00 |
| Mar 31, 2025 | 9.15 Mn |
| Dec 31, 2024 | 689,000.00 |
| Sep 30, 2024 | 8.89 Mn |
| Jun 30, 2024 | 52.07 Mn |
| Mar 31, 2024 | 51.28 Mn |
| Dec 31, 2023 | 50.48 Mn |
| Sep 30, 2023 | 90.11 Mn |
| Jun 30, 2023 | 88.14 Mn |
| Mar 31, 2023 | 86.28 Mn |
| Dec 31, 2022 | 85.37 Mn |
| Sep 30, 2022 | 84.65 Mn |
| Jun 30, 2022 | 84.27 Mn |
| Mar 31, 2022 | 425,315.00 |
API Access
Semnur Pharmaceuticals Non-Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-assets&ticker=SMNR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-assets", "ticker": "SMNR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-assets&ticker=SMNR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();